Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | PTAFR | P25105 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10365363 | 0.86 | POLB (0.44) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL9207857 | 0.86 | POLB (0.47) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL2898646 | 0.82 | POLB (0.41) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL522530 | 0.80 | CYP19A1 (0.41) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL10046459 | 0.77 | PTAFR (0.42) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL4035735 | 0.76 | NCF1 (0.41) | PTAFR | |
| SCHEMBL10046467 | 0.76 | ALDH1A1 (0.42) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL14047408 | 0.76 | TOP2A (0.39) | POLBCA1CA2CA4CA7 | |
| SCHEMBL122260 | 0.75 | ADORA3 (0.46) | POLBGAAALDH1A1RECQLPTAFR | |
| SCHEMBL10046471 | 0.74 | OPRM1 (0.44) | POLBGAAALDH1A1RECQLPTAFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5189118-A | MIXTURES OF 1-ISOPROPYL-2-ARYL IMIDAZOLE AND 1-ISOPROPYL-2-ARYL IMIDAZOLINE AS EPOXY RESIN CURATIVES | TEXACO CHEMICAL COMPANY (US) | 1993-02-23 | — | — | US | claimed |
| EP-0501074-A1 | Mixtures of 1-isopropyl-2-aryl imidazole and 1-isopropyl-2-aryl imidazoline as epoxy resin curative compositions | TEXACO CHEMICAL COMPANY (US) | 1992-09-02 | — | — | EP | claimed |
| JP-5078455-A | — | — | None | — | — | JP | disclosed |
| US-10662211-B2 | Catalysts and methods for polymer synthesis | Saurdi Aramco Technologies Company (SA) | 2020-05-26 | — | — | US | disclosed |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | NOVOMER, INC. | 2018-06-28 | — | — | US | disclosed |
| US-9951096-B2 | Catalysts and methods for polymer synthesis | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-04-24 | — | — | US | disclosed |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2017-06-29 | — | — | US | disclosed |
| US-20150126502-A1 | INHIBITORS OF POLO-LIKE KINASE | ELAN PHARM INC (US) | 2015-05-07 | — | — | US | disclosed |
| US-8859695-B2 | Activator for epoxy resin compositions | SIKA TECHNOLOGY AG (CH) | 2014-10-14 | — | — | US | disclosed |
| US-20130253094-A1 | ACTIVATOR FOR EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2013-09-26 | — | — | US | disclosed |
| US-20130231335-A1 | INHIBITORS OF POLO-LIKE KINASE | ELAN PHARMACEUTICALS, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2274359-B1 | ACTIVATOR FOR EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2012-03-07 | — | — | EP | disclosed |
| US-20110212942-A1 | INHIBITORS OF POLO-LIKE KINASE | ELAN PHARMACEUTICALS, INC. | 2011-09-01 | — | — | US | disclosed |
| US-20110039109-A1 | ACTIVATOR FOR EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2011-02-17 | — | — | US | disclosed |
| EP-2274359-A1 | ACTIVATOR FOR EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2011-01-19 | — | — | EP | disclosed |
| WO-2009133168-A1 | ACTIVATOR FOR EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2009-11-05 | — | — | WO | disclosed |
| EP-2113525-A1 | Activator for epoxy resin composites | Sika Technology AG (CH) | 2009-11-04 | — | — | EP | disclosed |
| JP-H0578455-A | CURING AGENT COMPOSITION FOR EPOXY RESIN AND CURING OF EPOXY RESIN | TEXACO CHEM CO | 1993-03-30 | — | — | JP | disclosed |
| US-5189118-A | MIXTURES OF 1-ISOPROPYL-2-ARYL IMIDAZOLE AND 1-ISOPROPYL-2-ARYL IMIDAZOLINE AS EPOXY RESIN CURATIVES | TEXACO CHEMICAL COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0501074-A1 | Mixtures of 1-isopropyl-2-aryl imidazole and 1-isopropyl-2-aryl imidazoline as epoxy resin curative compositions | TEXACO CHEMICAL COMPANY (US) | 1992-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212942-A1 | INHIBITORS OF POLO-LIKE KINASE | PLK1, POLK, POLR2E | POLB 9/4885GAA 670/4885ALDH1A1 4226/4885 |
| US-10662211-B2 | Catalysts and methods for polymer synthesis | PPOX, COASY, SOD1 | POLB 121/4885GAA 668/4885ALDH1A1 2255/4885 |
| US-20130231335-A1 | INHIBITORS OF POLO-LIKE KINASE | POLK, PLK1, POLR2E | POLB 9/4885GAA 712/4885ALDH1A1 4256/4885 |
| US-20150126502-A1 | INHIBITORS OF POLO-LIKE KINASE | POLK, PLK1, POLR2E | POLB 9/4885GAA 712/4885ALDH1A1 4256/4885 |
| US-20180179242-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | POLB 121/4885GAA 668/4885ALDH1A1 2255/4885 |
| US-20110039109-A1 | ACTIVATOR FOR EPOXY RESIN COMPOSITIONS | AHSA1, HSF1, HSPA1A | POLB 3152/4885GAA 665/4885ALDH1A1 1533/4885 |
| US-20170183369-A1 | CATALYSTS AND METHODS FOR POLYMER SYNTHESIS | PPOX, COASY, SOD1 | POLB 121/4885GAA 668/4885ALDH1A1 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.